- Home
- SMTI vs ATAI Comparison
SMTI vs ATAI Comparison
Compare SMTI & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- ATAI
- Stock Information
- Founded
- SMTI 1982
- ATAI 2018
- Country
- SMTI United States
- ATAI Germany
- Employees
- SMTI 108
- ATAI N/A
- Industry
- SMTI Medical/Dental Instruments
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- ATAI Health Care
- Exchange
- SMTI Nasdaq
- ATAI Nasdaq
- Market Cap
- SMTI 297.2M
- ATAI 271.6M
- IPO Year
- SMTI N/A
- ATAI 2021
- Fundamental
- Price
- SMTI $33.48
- ATAI $1.35
- Analyst Decision
- SMTI Strong Buy
- ATAI Strong Buy
- Analyst Count
- SMTI 2
- ATAI 4
- Target Price
- SMTI $47.00
- ATAI $9.00
- AVG Volume (30 Days)
- SMTI 22.3K
- ATAI 2.1M
- Earning Date
- SMTI 05-12-2025
- ATAI 03-17-2025
- Dividend Yield
- SMTI N/A
- ATAI N/A
- EPS Growth
- SMTI N/A
- ATAI N/A
- EPS
- SMTI N/A
- ATAI N/A
- Revenue
- SMTI $78,056,873.00
- ATAI $308,000.00
- Revenue This Year
- SMTI $35.26
- ATAI N/A
- Revenue Next Year
- SMTI $20.79
- ATAI $20.00
- P/E Ratio
- SMTI N/A
- ATAI N/A
- Revenue Growth
- SMTI 24.66
- ATAI N/A
- 52 Week Low
- SMTI $26.00
- ATAI $0.78
- 52 Week High
- SMTI $39.08
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- SMTI 49.57
- ATAI 37.68
- Support Level
- SMTI $30.81
- ATAI $1.33
- Resistance Level
- SMTI $34.92
- ATAI $1.48
- Average True Range (ATR)
- SMTI 1.31
- ATAI 0.10
- MACD
- SMTI 0.23
- ATAI -0.02
- Stochastic Oscillator
- SMTI 66.32
- ATAI 9.65
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.